An Open-Label, Multicenter, Dose Escalation and Expansion Phase 1B Study to Evaluate the Safety, Pharmacokinetics and Therapeutic Activity of RO6958688 in Combination with Atezolizumab in Patients with Locally Advanced and/or Metastatic CEA-Positive Solid Tumors

What is the purpose of this trial?

This is an open-label, multi-center, dose escalation and expansion Phase IB clinical study of RO6958688 in combination with atezolizumab.


Participation Guidelines

Ages: 18 years and older

Gender: Both


Hoffman-La Roche

Dates: 10/07/2016 - 03/01/2018

Last Updated: 12/20/2017

Study HIC#: 1603017493

Get Involved

For more information about this study, contact:
Jacqueline Rollin
+1 203-859-0001
jacqueline.rollin@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image